How to buy Isoray stock | $0.42

Isoray, Inc is a medical instruments & supplies business based in the US. Isoray shares (ISR) are listed on the NYSE MKT and all prices are listed in US Dollars. Isoray employs 53 staff and has a trailing 12-month revenue of around USD$9.7 million.

How to buy shares in Isoray

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Isoray. Find the stock by name or ticker symbol: ISR. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Isoray reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$0.42, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Isoray, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Isoray. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Isoray share price

Use our graph to track the performance of ISR stocks over time.

Isoray shares at a glance

• Key figures

Information last updated 2020-12-27.

Latest market close	USD$0.42
52-week range	USD$0.35 - USD$1.03
50-day moving average	USD$0.4103
200-day moving average	USD$0.5587
Wall St. target price	USD$1.28
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.077

Buy Isoray shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Isoray stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Isoray, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Isoray price performance over time

Historical closes compared with the close of $0.42 from 2020-12-09

1 week (2021-01-07)	-68.89%
1 month (2020-12-17)	-12.50%
3 months (2020-10-15)	-26.32%
6 months (2020-07-15)	-33.33%

1 year (2020-01-15)	-47.50%
2 years (2019-01-15)	10.53%
3 years (2018-01-13)	N/A
5 years (2016-01-15)	0.62

Isoray financials

Revenue TTM	USD$9.7 million
Gross profit TTM	USD$5.1 million
Return on assets TTM	-23.1%
Return on equity TTM	-55.49%
Profit margin	-34.29%
Book value	$0.074
Market capitalisation	USD$41 million

TTM: trailing 12 months

Shorting Isoray shares

There are currently 632,520 Isoray shares held short by investors – that's known as Isoray's "short interest". This figure is 23.9% down from 830,863 last month.

There are a few different ways that this level of interest in shorting Isoray shares can be evaluated.

Isoray's "short interest ratio" (SIR)

Isoray's "short interest ratio" (SIR) is the quantity of Isoray shares currently shorted divided by the average quantity of Isoray shares traded daily (recently around 1.4 million). Isoray's SIR currently stands at 0.46. In other words for every 100,000 Isoray shares traded daily on the market, roughly 460 shares are currently held short.

However Isoray's short interest can also be evaluated against the total number of Isoray shares, or, against the total number of tradable Isoray shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Isoray's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Isoray shares in existence, roughly 10 shares are currently held short) or 0.0073% of the tradable shares (for every 100,000 tradable Isoray shares, roughly 7 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Isoray.

Find out more about how you can short Isoray stock.

Isoray share dividends

We're not expecting Isoray to pay a dividend over the next 12 months.

Have Isoray's shares ever split?

Isoray's shares were split on a 1:30 basis on 17 August 2005. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Isoray shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Isoray shares which in turn could have impacted Isoray's share price.

Isoray share price volatility

Over the last 12 months, Isoray's shares have ranged in value from as little as $0.35 up to $1.03. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Isoray's is 1.8619. This would suggest that Isoray's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Isoray overview

Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. Isoray, Inc. was founded in 1998 and is headquartered in Richland, Washington.

Frequently asked questions

• What percentage of Isoray is owned by insiders or institutions?

  Currently 1.282% of Isoray shares are held by insiders and 7.873% by institutions.

• How many people work for Isoray?

  Latest data suggests 53 work at Isoray.

• When does the fiscal year end for Isoray?

  Isoray's fiscal year ends in June.

• Where is Isoray based?

  Isoray's address is: 350 Hills Street, Richland, WA, United States, 99354

• What is Isoray's ISIN number?

  Isoray's international securities identification number is: US46489V1044

• What is Isoray's CUSIP number?

  Isoray's Committee on Uniform Securities Identification Procedures number is: 46489V104